Related Experiment Videos
[Scarlatiniform, morbilliform, rubeoliform erythemas. Diagnostic orientation]
1Service de dermatologie Hôpital de l'Antiquaille, Lyon.
La Revue Du Praticien
|May 21, 1991
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
[Improvement of pulmonary angiography in the framework of a maintenance of certification].
Journal de radiologie·2011
[Delayed myocardial enhancement: Optimizing the MR imaging protocol].
Journal de radiologie·2010
[Urokinase in the management of occluded PICC lines].
Journal de radiologie·2010
[Imaging of mediastinal tumors].
Revue de pneumologie clinique·2010
Structure of Debaryomyces castellii CBS 2923 phytase.
Acta crystallographica. Section F, Structural biology and crystallization communications·2009
[Nasopharyngeal carcinoma].
Journal de radiologie·2008
[In utero treatment of twin-to-twin transfusion syndrome].
La Revue du praticien·2026
[In utero treatment of spina bifida].
La Revue du praticien·2026
[Syphilis and pregnancy].
La Revue du praticien·2026
[Second-line treatments for Parkinson's disease].
La Revue du praticien·2026
[Ageism in healthcare: sad prejudices!]
La Revue du praticien·2026
[Vaccination for pregnant women].
La Revue du praticien·2026
Nose-to-brain delivery of a novel boronated curcuminoid via cyclodextrins: Biodistribution toward potential BNCT applications in Alzheimer's disease.
Journal of controlled release : official journal of the Controlled Release Society·2026
Self-supervised small vessel segmentation with shape-aware geometric models and attention.
Medical image analysis·2026
Isolation and identification of two novel oxyphenisatin analogues found as adulterants in health food products.
Journal of pharmaceutical and biomedical analysis·2026
YK-4-250, a synthetic telmisartan-tempol conjugate: crystal structure of a stabilized free radical containing an angiotensin AT1 receptor inhibitor.
Acta crystallographica. Section C, Structural chemistry·2026
Discovery of TL10: A Soluble and Long-Acting MC4R Agonist with Tunable Lipidation for Sustained Pharmacological Activity.
Journal of medicinal chemistry·2026